Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00642213 · ClinicalTrials.gov registry record

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

A clinical trial of Ischemic Stroke and Hemorrhage, sponsored by University of Cincinnati.

Active
Registry status
1,500
Enrollment target
1
Study location

NCT00642213 is a study of Ischemic Stroke and Hemorrhage that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 1,500 participants, roughly in line with the 1,441-participant average among 66 other Ischemic Stroke trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00642213, a study of Ischemic Stroke and Hemorrhage, is active but no longer recruiting, sponsored by University of Cincinnati.

ACTIVE NOT RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom 215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention, and evaluation of public health efforts to decrease the mortality and morbidity due to stroke in the United States. We have completed this goal for 1993-94, 1999, 2005, 2010 and 2015. We are in the process of collecting this data for 2020. In the 2020 study period we will also be ascertaining 3 year recurrence rates for all incident stroke events.

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 1993-07
Est. Completion 2025-06-30

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT00642213

The ClinicalTrials.gov registry entry for NCT00642213 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,441-participant average among 66 other Ischemic Stroke trials with a reported enrollment target. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00642213 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00642213 about?

NCT00642213 is a clinical study titled "A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites". Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom 215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention, and evaluation of public hea...

What is the current status of trial NCT00642213?

This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 1993-07. Estimated completion is 2025-06-30.

What conditions does trial NCT00642213 study?

This clinical trial studies the following conditions: Ischemic Stroke, Hemorrhage, TIA.

Who is sponsoring clinical trial NCT00642213?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00642213 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.